REYON Pharmaceutical (102460.KS) Earnings Analysis
REYON Pharmaceutical (102460.KS) has no confirmed upcoming earnings date. Trailing P/E -4.44.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 102460.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 102460.KS. This page updates as the calendar is published.
102460.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | 138.82 KRW | n/a | n/a | n/a |
| 2024-09-30 | 34 KRW | n/a | n/a | n/a |
102460.KS valuation and analyst view
| Trailing P/E | -4.44 |
|---|---|
| Trailing EPS | -2,223.35516 KRW |
| Price / book | 0.87 |
| Dividend yield | 0.00% |
| Market cap | 179.19B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is REYON Pharmaceutical (102460.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 102460.KS. This page updates as the calendar is published.
Did 102460.KS beat earnings last quarter?
Consensus estimate data was not available for 102460.KS's 2024-12-31 report.
What is 102460.KS's current P/E ratio and EPS?
102460.KS trades at a trailing P/E of -4.44 on trailing EPS of -2223.3551605692164 KRW.
What do analysts rate 102460.KS?
102460.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.